Recital 147
Access to testing facilities
It is appropriate that the Commission facilitates, to the extent possible, access to testing and experimentation facilities to bodies, groups or laboratories established or accredited pursuant to any relevant Union harmonisation legislation and which fulfil tasks in the context of conformity assessment of products or devices covered by that Union harmonisation legislation. This is, in particular, the case as regards expert panels, expert laboratories and reference laboratories in the field of medical devices pursuant to Regulations (EU) 2017/745 and (EU) 2017/746.
Source and verification
This is the text of Recital 147 of Regulation (EU) 2024/1689, unchanged since it was adopted. It has been checked against the consolidated text on EUR-Lex. Where this page and EUR-Lex disagree, EUR-Lex governs.
Working out what this means for your systems? Beyond Recital 147, the EU AI Act compliance checker screens one system for scope, prohibitions, high-risk routes and transparency duties, free and without a sign-up. For many systems rather than one, book a demo and Holistic AI will assess them with you.